Pre-transplant tests were conducted to assess various variables, including hemoglobin levels, platelet count, model for end-stage liver disease (MELD), creatinine levels, international normalized ratio (INR), cold ischemia time (CIT), warm ischemia time (WIT), albumin levels, and volume of recovered blood (Table 2). This evidence concerns the gene ALB and End Stage Liver Disease.